Contact
Please use this form to send email to PR contact of this press release:
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Complete Vaccine™ Development Program
TO:
Please use this form to send email to PR contact of this press release:
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Complete Vaccine™ Development Program
TO: